Clinical trials: Depressive, Symptoms Depressive Disorder, Depression
Postmenopausal, Depressive Symptom
Breathing Exercises on Depression in Postmenopausal Women
Evaluate the effect of breathing exercises on depression and sexual function in postmenopausal women
- Conditions
- Postmenopausal, Depressive Symptom, Breathing Exercises
- Trial name
- NCT06741384
- Testing
- Diaphragmatic breathing exercises, Aerobic training
- Volunteers
- 60 people
- Sponsor
- Middle East University
Posttraumatic Stress Disorder (PTSD), Anxiety
Mindful Self-Compassion to Address PTSD and Substance Use in Unhoused Women
Trauma exposure, posttraumatic stress disorder (PTSD), and substance use disorder (SUD) present major threats to public health. PTSD and SUD are major correlates of disability, often resulting in severe social and occupational…
- Conditions
- Posttraumatic Stress Disorder (PTSD), Anxiety, Depression - Major Depressive Disorder
- Trial name
- MSC for PTSD (NCT06646692)
- Testing
- Mindful Self Compassion, Treatment as Usual (TAU)
- Where
- United States
- Volunteers
- 230 people
- Sponsor
- University of California, Los Angeles
Obsessive-Compulsive Disorder, Generalized Anxiety Disorder
The Role of Cognitive Control in the Transdiagnostic Conceptualization of "Intrusive Thoughts"
The investigators are examining whether difficulties with cognitive control (i.e., the ability to stop one's thought process and shift attention) is a common problem across three types of repetitive, negative thinking: obsessions…
- Conditions
- Obsessive-Compulsive Disorder, Generalized Anxiety Disorder, Major Depressive Disorder
- Trial name
- NCT03414619
- Testing
- Cognitive Control Tasks and Script Driven Imagery
- Where
- United States
- Volunteers
- 75 people, healthy volunteers welcome
- Sponsor
- Massachusetts General Hospital
Depressive Symptoms, Anxiety
The Impact of PM+For Moms Intervention on Improving Mother's Mental Health in Zambia (PM+FM)
CMHD are particularly prevalent among women, posing a major threat to their own and their children's wellbeing. Despite the high prevalence of CMHD and the existence of effective treatments, interventions supporting women living…
- Conditions
- Depressive Symptoms, Anxiety, Trauma, Psychological
- Trial name
- PM+FM (NCT05627206)
- Testing
- Problem Management + For Moms
- Where
- Zambia
- Volunteers
- 270 people
- Sponsor
- Swiss Tropical & Public Health Institute
Postpartum Depression
Mom: Managing Our Mood, Part of The Family Help Program
The purpose of the MOM: Managing Our Mood Program (part of Family Help) is to evaluate the effectiveness of the Family Help distance intervention compared to usual or standard care typically provided to women with mild to…
- Trial name
- MOM (NCT00795652)
- Testing
- Distance Treatment for postpartum depression
- Where
- Canada
- Volunteers
- 62 people, healthy volunteers welcome
- Sponsor
- IWK Health Centre
Depressive Disorder
Depression Attention for Women Now (The DAWN Study)
Major depressive disorder (MDD) is a common disabling illness that disproportionately affects women, with prevalence rates two times those of men.
- Trial name
- DAWN (NCT01096316)
- Testing
- Depression Care Management
- Where
- 2 sites in United States
- Volunteers
- 205 people
- Sponsor
- University of Washington
Major Depressive Disorder, Major Depressive Episode
Glabellar Botulinum Toxin Injections for the Treatment of Geriatric Depression
The effectiveness of glabellar injection of botulinum toxin type A (BTA) in treating depression has not yet been investigated in elderly patients.
- Conditions
- Major Depressive Disorder, Major Depressive Episode, Treatment Resistant Depression
- Trial name
- BOTDEP (NCT03833063)
- Testing
- botulinum toxin A
- Sponsor
- Helse Stavanger HF
Major Depressive Disorder
Antidepressant Incomplete Response Depression
Observational, non-interventional, longitudinal, prospective,multicenter, open label (No treatment is involved). 3 assessment will be carried out .
- Trial name
- DRIA (NCT00782964)
- Where
- 48 sites in Spain
- Volunteers
- 364 people
- Sponsor
- AstraZeneca
Depression
Investigation to Understand and Optimize Psilocybin
This study will examine the effects of a single dose of psilocybin, administered with psychological support, on symptoms of depression.
- Trial name
- OPTIMIZE (NCT06512194)
- Testing
- Psilocybin, Transcutaneous Auricular Vagus Nerve Stimulation (taVNS)
- Where
- United States
- Volunteers
- 141 people
- Sponsor
- Charles Raison
Anxiety Symptoms, Depressive Symptoms
ICBT for Anxiety and Depressive Symptoms in Brazilian Young Adults
This study aims to investigate the effects of a selfguided internet-based cognitive behavioral therapy (ICBT) program on depressive and anxiety symptoms in young Brazilian adults.
- Trial name
- NCT06633679
- Testing
- Se Cuida Intervention
- Where
- Brazil
- Volunteers
- 200 people, healthy volunteers welcome
- Sponsor
- Linkoeping University
Major Depressive Disorder
Amygdala Neurofeedback for Depression - Large Scale Clinical Trial
The goal of this study is to evaluate whether rtfMRI-nf training to increase the amygdala response to positive memories may serve as a stand-alone intervention for major depressive disorder
- Trial name
- NCT05703256
- Testing
- Amygdala real-time fMRI neurofeedback
- Where
- United States
- Volunteers
- 200 people
- Sponsor
- Kymberly Young
Treatment Resistant Depression
PCS in Severe Treatment Resistant Depression
This research study is designed to test if electrical stimulation of the surface of the brain in the frontal region will help treat depressive symptoms.
- Trial name
- NCT04124341
- Testing
- Prefrontal Cortical Stimulation (PCS)
- Where
- United States
- Volunteers
- 15 people
- Sponsor
- University of Minnesota
Major Depression
Optimizing Antidepressant Treatment by Genotype-dependent Adjustment of Medication According to the ABCB1 Gene
The study evaluates the ABCB1-genotype dependent efficacy of a quick dose-escalation strategy within 28 days of treatment with approved antidepressants that are known substrates of the P-glycoprotein, an efflux pump of the…
- Trial name
- NCT02237937
- Testing
- Paroxetine, Sertraline, Citalopram
- Where
- Germany
- Volunteers
- 80 people, healthy volunteers welcome
- Sponsor
- HolsboerMaschmeyer NeuroChemie GmbH
Major Depressive Disorder
Early Versus Delayed Switch in Medication in Patients With Major Depressive Disorder
This study investigates two different approaches to the change in antidepressant treatment when an initial treatment is not effective: early intervention or delayed intervention. Two hypothesis will be tested: 1.
- Trial name
- NCT00810069
- Testing
- Duloxetine Hydrochloride, Escitalopram
- Where
- 60 sites in Denmark, France and 9 more
- Volunteers
- 840 people
- Sponsor
- Eli Lilly and Company
Major Depressive Disorder
Safety and Efficacy of Levomilnacipran ER (F2695 SR) in Adults With Fatigue Associated With Major Depressive Disorder
The purpose of the study is to evaluate the efficacy, safety and tolerability of Levomilnacipran ER for the treatment of fatigue associated with major depressive disorder (MDD).
- Trial name
- NCT01254305
- Testing
- Levomilnacipran ER, Paroxetine, Sertraline, Citalopram or Fluoxetine.
- Where
- 20 sites in United States
- Volunteers
- 262 people
- Sponsor
- Forest Laboratories
Depressive Symptoms
Reducing Depressive Symptoms Among Rural African Americans
Rural African Americans are disproportionately impacted by social stressors that place them at risk for experiencing elevated depressive symptoms.
- Trial name
- REJOICE (NCT02860741)
- Testing
- REJOICE, Control
- Where
- 4 sites in United States
- Volunteers
- 184 people
- Sponsor
- University of Arkansas
Major Depressive Disorder, Anhedonia
Depression and Dopamine Transporter Function Study Using C-11 Altropane
Major depressive disorder (MDD) is often characterized by anhedonia and impaired ability to modulate behavior as a function of rewards.
- Trial name
- NCT01701141
- Where
- 2 sites in United States
- Volunteers
- 150 people, healthy volunteers welcome
- Sponsor
- Mclean Hospital
Depression - Major Depressive Disorder, Anxiety
No Time to Wait: Single Session Intervention
Mental health problems in youth are prevalent, but early intervention effectively reduces symptoms, substance abuse risk, suicide, and comorbidities.
- Trial name
- NCT07383467
- Testing
- Online Single Session Intervention on Growth Mindset
- Where
- Hong Kong
- Volunteers
- 124 people
- Sponsor
- United Christian Hospital
Depression, Depressive Disorder
Optimizing Electroconvulsive Therapy for Depression
This study will evaluate the effectiveness of electroconvulsive therapy (ECT) administered with medication for the treatment of a major depressive episode (unipolar or bipolar) and will compare two types of ECT.
- Conditions
- Depression, Depressive Disorder, Bipolar Disorder
- Trial name
- NCT00045916
- Testing
- High dosage electroconvulsive therapy, Nortriptyline, Venlafaxine
- Where
- 4 sites in United States
- Volunteers
- 340 people
- Sponsor
- New York State Psychiatric Institute
Cannabis Use Disorder, Major Depressive Disorder
Effects of Cannabis Abstinence on Symptoms and Cognition in Depression
The objective of this study is to assess the changes in symptoms and cognition that occur after a 28-day abstinence period in patients with comorbid Cannabis Use Disorder (CUD) and Major Depression (MDD).
- Conditions
- Cannabis Use Disorder, Major Depressive Disorder, Cognition
- Trial name
- NCT03624933
- Testing
- Weekly Behavioral Coaching Session, Contingency Management
- Where
- Canada
- Volunteers
- 19 people
- Sponsor
- Centre for Addiction and Mental Health
The first 1,020 results can be paged through. Add a filter or change the sort order to reach the rest.